- Home
- NSPR vs PMVP Comparison
NSPR vs PMVP Comparison
Compare NSPR & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- PMVP
- Stock Information
- Founded
- NSPR 2005
- PMVP 2013
- Country
- NSPR United States
- PMVP United States
- Employees
- NSPR N/A
- PMVP N/A
- Industry
- NSPR Medical/Dental Instruments
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- NSPR Health Care
- PMVP Health Care
- Exchange
- NSPR Nasdaq
- PMVP Nasdaq
- Market Cap
- NSPR 79.7M
- PMVP 71.9M
- IPO Year
- NSPR N/A
- PMVP 2020
- Fundamental
- Price
- NSPR $2.60
- PMVP $0.88
- Analyst Decision
- NSPR Strong Buy
- PMVP Strong Buy
- Analyst Count
- NSPR 2
- PMVP 2
- Target Price
- NSPR $4.75
- PMVP $5.50
- AVG Volume (30 Days)
- NSPR 48.2K
- PMVP 165.3K
- Earning Date
- NSPR 05-09-2025
- PMVP 05-12-2025
- Dividend Yield
- NSPR N/A
- PMVP N/A
- EPS Growth
- NSPR N/A
- PMVP N/A
- EPS
- NSPR N/A
- PMVP N/A
- Revenue
- NSPR $7,009,000.00
- PMVP N/A
- Revenue This Year
- NSPR $28.93
- PMVP N/A
- Revenue Next Year
- NSPR $172.18
- PMVP N/A
- P/E Ratio
- NSPR N/A
- PMVP N/A
- Revenue Growth
- NSPR 12.96
- PMVP N/A
- 52 Week Low
- NSPR $2.07
- PMVP $0.82
- 52 Week High
- NSPR $3.80
- PMVP $2.26
- Technical
- Relative Strength Index (RSI)
- NSPR 49.84
- PMVP 33.62
- Support Level
- NSPR $2.40
- PMVP $0.85
- Resistance Level
- NSPR $2.79
- PMVP $1.04
- Average True Range (ATR)
- NSPR 0.16
- PMVP 0.06
- MACD
- NSPR 0.01
- PMVP -0.01
- Stochastic Oscillator
- NSPR 60.42
- PMVP 10.42
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.